Jean‐Michel Pignon

1.5k total citations
15 papers, 575 citations indexed

About

Jean‐Michel Pignon is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Jean‐Michel Pignon has authored 15 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Jean‐Michel Pignon's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jean‐Michel Pignon is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jean‐Michel Pignon collaborates with scholars based in France and Switzerland. Jean‐Michel Pignon's co-authors include Michel Tulliez, H Rochant, Hélène Jouault, William Vainchenker, Stéphane Giraudier, François‐Xavier Mahon, Gaëlle Guillerm, Delphine Réa, Martine Gardembas and Philippe Rousselot and has published in prestigious journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

Jean‐Michel Pignon

14 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐Michel Pignon France	9	417	282	224	130	71	15	575
M. T. Daniel France	7	385 0.9×	240 0.9×	67 0.3×	52 0.4×	129 1.8×	10	494
D. Garau Italy	13	340 0.8×	192 0.7×	45 0.2×	62 0.5×	115 1.6×	29	502
Hien K. Duong United States	8	261 0.6×	107 0.4×	62 0.3×	100 0.8×	104 1.5×	30	425
Sara Mach‐Pascual Switzerland	9	218 0.5×	161 0.6×	49 0.2×	73 0.6×	101 1.4×	12	362
Tiejun Qin China	15	471 1.1×	323 1.1×	91 0.4×	36 0.3×	232 3.3×	88	599
Patrizia Guglielmo Italy	10	218 0.5×	172 0.6×	62 0.3×	40 0.3×	154 2.2×	32	411
Kátia Bórgia Barbosa Pagnano Brazil	13	384 0.9×	290 1.0×	133 0.6×	35 0.3×	163 2.3×	90	569
Dmitriy Berenzon United States	13	301 0.7×	215 0.8×	68 0.3×	51 0.4×	223 3.1×	28	535
Arjan van de Loosdrecht Netherlands	9	547 1.3×	252 0.9×	22 0.1×	105 0.8×	123 1.7×	22	643
Florence Pasquier France	11	169 0.4×	135 0.5×	42 0.2×	61 0.5×	112 1.6×	23	339

Countries citing papers authored by Jean‐Michel Pignon

Since Specialization

Citations

This map shows the geographic impact of Jean‐Michel Pignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Michel Pignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Michel Pignon more than expected).

Fields of papers citing papers by Jean‐Michel Pignon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Michel Pignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Michel Pignon. The network helps show where Jean‐Michel Pignon may publish in the future.

Co-authorship network of co-authors of Jean‐Michel Pignon

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Michel Pignon. A scholar is included among the top collaborators of Jean‐Michel Pignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Michel Pignon. Jean‐Michel Pignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Réa, Delphine, Franck E. Nicolini, Michel Tulliez, et al.. (2019). Prognostication of Molecular Relapses after Dasatinib or Nilotinib Discontinuation in Chronic Myeloid Leukemia (CML): A FI-LMC STOP 2G-TKI Study Update. Blood. 134(Supplement_1). 30–30. 15 indexed citations

Fournier, Élise, Jean‐Michel Pignon, Catherine Roche‐Lestienne, et al.. (2019). Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature. Leukemia & lymphoma. 60(7). 1827–1830. 12 indexed citations

Réa, Delphine, Franck E. Nicolini, Michel Tulliez, et al.. (2016). Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study. Blood. 129(7). 846–854. 230 indexed citations

Lannoy, Damien, et al.. (2006). Gemtuzumab ozogamicin-induced sinusoidal obstructive syndrome treated with defibrotide: a case report. Journal of Clinical Pharmacy and Therapeutics. 31(4). 389–392. 2 indexed citations

Zittoun, J, Carole Tonetti, Dominique Bories, Jean‐Michel Pignon, & Michel Tulliez. (1998). Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: A study in 52 healthy subjects. Metabolism. 47(11). 1413–1418. 34 indexed citations

Pignon, Jean‐Michel. (1998). [Bcr-abl translocation: diagnostic methods and clinical value].. PubMed. 56(1). 57–63. 1 indexed citations

Pignon, Jean‐Michel. (1997). Leucémie myéloïde chronique: données récentes. Revue Française des Laboratoires. 1997(296). 17–20. 1 indexed citations

Pignon, Jean‐Michel. (1997). C-kit mutations and mast cell disorders A model of activating mutations of growth factor receptors. PubMed. 39(2). 114–116. 10 indexed citations

Pignon, Jean‐Michel, et al.. (1997). A new c‐kit mutation in a case of aggressive mast cell disease. British Journal of Haematology. 96(2). 374–376. 126 indexed citations

10.

Pignon, Jean‐Michel. (1997). Thrombocytémie essentielle. Revue Française des Laboratoires. 1997(296). 27–31. 3 indexed citations

11.

Leroy‐Matheron, Catherine, et al.. (1996). The 1691 G → A Mutation in the Factor V Gene: Relationship to Activated Protein C (APC) Resistance and Thrombosis in 65 Patients. Thrombosis and Haemostasis. 75(1). 4–10. 22 indexed citations

12.

Pignon, Jean‐Michel. (1995). Intérêt de la biologie moléculaire pour l'étude des hémopathies malignes myéloïdes. Revue Française des Laboratoires. 1995(275). 59–67. 1 indexed citations

13.

Pignon, Jean‐Michel, et al.. (1993). Danazol in autoimmune haemolytic anaemia. British Journal of Haematology. 83(2). 343–345. 44 indexed citations

14.

Chevalier, Xavier, Olivier Hermine, Alain Rahmouni, et al.. (1993). Bilateral tumoral infiltration of the achilles tendons revealing chronic myelomonocytic leukemia. Arthritis & Rheumatism. 36(6). 852–856. 4 indexed citations

15.

Pignon, Jean‐Michel, Tawfiq Henni, Serge Amselem, et al.. (1990). Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia.. PubMed. 4(2). 83–6. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact